Human Psychopharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.0 | Q3 | 47.9% | 0.662 | Q2 | 71.0% |
| 2024 | 1.7 | Q3 | 44.1% | 0.510 | Q3 | 62.8% |
| 2023 | 1.8 | Q3 | 76.9% | 0.541 | Q3 | 67.4% |
| 2022 | 1.7 | Q3 | 53.8% | 0.449 | Q3 | 62.9% |
| 2021 | 2.1 | Q2 | 73.1% | 0.448 | Q3 | 63.7% |
| 2020 | — | — | 0.461 | Q3 | 63.8% | |
| 2019 | — | — | 0.714 | Q2 | 77.4% | |
| 2018 | — | — | 0.657 | Q2 | 73.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0885-6222
ISSN
1099-1077
country
GBcoverage
1986-2026